NATASHA MAGUIRE: Open Payments
NPI 1477011062 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,529 in 128 payments from 19 companies in 2025. Trend: 2023 $1,835 · 2024 $1,988 · 2025 $2,529
Food & beverage: $2,529
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 13 | $418 |
| ABBVIE INC. | 22 | $401 |
| Neurocrine BioSciences, Inc. | 10 | $213 |
| ACADIA Pharmaceuticals Inc | 8 | $208 |
| Teva Pharmaceuticals USA, Inc. | 15 | $203 |
| Amneal Pharmaceuticals LLC | 10 | $202 |
| Lundbeck LLC | 7 | $148 |
| MDD US Operations, LLC | 11 | $142 |
| Supernus Pharmaceuticals, Inc. | 8 | $114 |
| Otsuka America Pharmaceutical, Inc. | 6 | $110 |
Products named: Leqembi, INGREZZA, NUPLAZID, VYALEV, CREXONT, REXULTI, AUSTEDO XR, Gocovri.
Industry payments across FL — which companies pay providers there.
